Lantheus
- Market cap
- 6.54B
- P/E (TTM)i
- 23.97
- P/Bi
- 4.99
- EPSi
- 3.41
- Div yieldi
- 0.00%
- 52W posi
- 81%
Anonymous reader poll. Unscientific, not investment advice.
About Lantheus
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
- Founded
- 1956
- CEO
- Ms. Mary Anne Heino
- Employees
- 1,193
- Headquarters
- Bedford, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- lantheus.com
Company profile
- Exchange
- US
- Symbol
- LNTH
- Market-cap rank
- #1847
- Listing date
- 2015-06-25
- Market cap
- 6.54B
- Float cap
- 5.87B
- Shares out
- 65.30M
- Float shares
- 58.64M
Sectors & themes
Quote time 2026-10-08 01:17:57 · For reference only, not investment advice and not tailored to your situation.